A Study Of Pregabalin (Lyrica) Drug Levels In Urine, Plasma And Breast Milk Of Healthy Lactating Women
Status:
Completed
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
This is a pharmacokinetic study to determine the safety and tolerability of pregabalin in
healthy lactating women. The objectives are to determine whether pregabalin is secreted in
breast milk and if so, to characterize pregabalin pharmacokinetics in breast milk. Other
objectives are to estimate potential infant exposure to pregabalin if administered to
lactating women and to characterize the safety and tolerability of pregabalin in lactating
women.
Phase:
Phase 4
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.